Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

15.85
Delayed Data
As of Mar 24
 +0.10 / +0.63%
Today’s Change
9.80
Today|||52-Week Range
18.92
+2.92%
Year-to-Date

Today’s Trading

Previous close15.75
Today’s open15.85
Day’s range15.55 - 15.95
Volume407,266
Average volume (3 months)238,870
Market cap$419.9M
Dividend yield4.22%
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-28.44%
Earnings growth (this year)+22.96%
Earnings growth (next 5 years)+274.70%
Revenue growth (last year)--
P/E ratioNM
Price/Sales10,755.10
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
BYSIBeyondspring Inc-0.60-3.12%
CRVSCorvus Pharmaceutica...+0.46+2.25%
KPTIKaryopharm Therapeut...+0.12+1.16%
MYOKMyoKardia Inc+0.70+5.04%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 19, 2017
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$29.0K
Annual profit (last year)-$111.6M
Net profit margin-384,951.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, COO, Director &
CMO
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs